Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,613 | -$15,596 | -$8,230 | -$24,384 |
| Dep. & Amort. | $115 | $5 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,566 | $624 | $219 |
| Change in WC | $3,967 | $1,653 | $195 | -$391 |
| Other Non-Cash | $2,936 | $0 | $0 | $22,964 |
| Operating Cash Flow | -$14,595 | -$11,371 | -$7,408 | -$1,589 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,178 | -$52 | $0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,178 | -$52 | $0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$50 | $200 |
| Stock Issued | $15,949 | $15,696 | $3,389 | $18,649 |
| Stock Repurch. | $0 | $0 | -$100 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$232 | -$7 | $0 |
| Financing Cash Flow | $15,949 | $15,464 | $3,232 | $18,849 |
| Forex Effect | -$4 | $33 | -$32 | -$5 |
| Net Chg. in Cash | $172 | $4,073 | -$4,208 | $17,253 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,510 | $13,437 | $17,644 | $391 |
| End Cash | $17,682 | $17,510 | $13,437 | $17,644 |
| Free Cash Flow | -$15,773 | -$11,424 | -$7,408 | -$1,590 |